LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,187,190 | -61.1% | 107,000 | -60.0% | 0.11% | -66.4% |
| Q2 2023 | $18,465,525 | +303.1% | 267,500 | +181.6% | 0.33% | +267.4% |
| Q1 2023 | $4,580,900 | +81.7% | 95,000 | +88.1% | 0.09% | +128.2% |
| Q4 2022 | $2,520,960 | +25.6% | 50,500 | +2.6% | 0.04% | +39.3% |
| Q3 2022 | $2,007,000 | -53.2% | 49,210 | -36.8% | 0.03% | -52.5% |
| Q2 2022 | $4,284,000 | +41.2% | 77,900 | +29.8% | 0.06% | +73.5% |
| Q3 2021 | $3,034,000 | -17.9% | 60,000 | -33.3% | 0.03% | -29.2% |
| Q2 2021 | $3,694,000 | – | 90,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |